title: [Case report; Disseminated Mycobacterium abscessus infection with hemophagocytic syndrome during treatment of chronic lymphocytic leukemia].
authors.forename: Seiichiro
authors.initials: S
authors.lastname: Katagiri
authors.forename: Seiichiro
authors.initials: S
authors.lastname: Yoshizawa
authors.forename: Moritaka
authors.initials: M
authors.lastname: Gotoh
authors.forename: Itaru
authors.initials: I
authors.lastname: Nakamura
authors.forename: Kazuma
authors.initials: K
authors.lastname: Ohyashiki
mesh_terms: D000583:Amikacin / Q000008:administration & dosage; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D017291:Clarithromycin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage; D016867:Immunocompromised Host; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D064704:Levofloxacin / Q000008:administration & dosage; D051359:Lymphohistiocytosis, Hemophagocytic / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000150:complications* / Q000188:drug therapy*; D009894:Opportunistic Infections / Q000150:complications* / Q000188:drug therapy; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D064704:Levofloxacin; D015378:Imipenem; D000583:Amikacin; D003520:Cyclophosphamide; D011239:Prednisolone; D017291:Clarithromycin